首页> 美国卫生研究院文献>Heliyon >Iron deficiency negatively regulates protein methylation via the downregulation of protein arginine methyltransferase
【2h】

Iron deficiency negatively regulates protein methylation via the downregulation of protein arginine methyltransferase

机译:铁缺乏通过蛋白质精氨酸甲基转移酶的下调来调节蛋白质甲基化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Iron is an essential trace metal for all biological processes and plays a role in almost every aspect of body growth. Previously, we found that iron-depletion downregulated the expression of proteins, arginine methyltransferase-1 and 3 (PRMT1 and PRMT3), by an iron-specific chelator, deferoxamine (DFO), in rat liver FAO cell line using DNA microarray analysis (unpublished data). However, regulatory mechanisms underlying the association between iron deficiency and PRMT expression are unclear in vitro and in vivo. In the present study, we revealed that the treatment of cells with two iron-specific chelators, DFO and deferasirox (DFX), downregulated the gene and protein expression of PRMT1 and 3 as compared with the untreated cells. Subsequently, DFO and DFX treatments decreased protein methylation. Importantly, these effects were attenuated by a holo-transferrin treatment. Furthermore, weanling Wistar-strain rats were fed a control diet or an iron-deficient diet for 4 weeks. Dietary iron deficiency was found to decrease the concentration of hemoglobin and liver iron while increasing the heart weight. PRMT and protein methylation levels were also significantly reduced in the iron-deficient group as compared to the control group. To our knowledge, this is the first study to demonstrate that PRMT levels and protein methylation are reduced in iron-deficient models, in vitro and in vivo.
机译:铁是所有生物过程的必需痕量金属,在身体生长的几乎每个方面都发挥作用。以前,我们发现铁耗尽下调了使用DNA微阵列分析的大鼠肝脏粮农组细胞中的铁特异性螯合剂,蛋白质,精氨酸甲基转移酶-1和3(PRMT1和PRMT3)的表达(PRMT1和PRMT3)(PROFTOROMINE(DFO)(未发表数据)。然而,在缺铁与PRMT表达之间的关联的监管机制尚不清楚体外和体内。在本研究中,我们透露,与未处理的细胞相比,将具有两种铁特异性螯合剂,DFO和脱硅酸硅(DFX)的细胞进行治疗,下调PRMT1和3的基因和蛋白表达。随后,DFO和DFX治疗减少了蛋白质甲基化。重要的是,这些效果通过Holo-Transionrin治疗衰减。此外,将断奶菌菌株大鼠饲喂一次控制饮食或铁缺乏饮食4周。发现膳食铁缺乏症在增加心脏体重时降低血红蛋白和肝脏掺杂的浓度。与对照组相比,铁缺陷组中,PRMT和蛋白质甲基化水平也显着降低。据我们所知,这是第一项研究表明PRMT水平和蛋白质甲基化的铁缺乏型模型,体外和体内。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号